To our knowledge, the solely in vivo study on a spontaneous mammary tumor model was reported by Provinciali et al. who claimed how resveratrol supplementation delays tumor onset, growth and metastases in HER2/neu transgenic female mice [12]. This evidence concerns the gene ERBB2 and breast cancer.